XML 117 R19.htm IDEA: XBRL DOCUMENT
v3.20.1

Note 12 - Other Accrued Liabilities | 12 Months Ended
--- | ---
Dec. 31, 2019
Notes to Financial Statements |
Other Liabilities Disclosure [Text Block] | 12— OTHER ACCRUED LIABILITIES Other accrued liabilities consist of the following:
|  | December 31,
|  | 2019 |  | 2018
Retirement indemnities |  |  | 2,444 |  |  |  | 2,287 |
Provision for warranty costs |  |  | 370 |  |  |  | 547 |
Accruals for payroll and associated taxes |  |  | 738 |  |  |  | 680 |
Conditional government advances |  |  | 1,071 |  |  |  | 1,039 |
Value added tax payable |  |  | 557 |  |  |  | 327 |
Advances received from customers |  |  | - |  |  |  | 115 |
Provision for Asset Retirement Obligation (Japan) |  |  | 117 |  |  |  | 118 |
Provision for employee termination indemnities (Italy) |  |  | - |  |  |  | 369 |
Provision for employee termination indemnities (Korea) |  |  | 56 |  |  |  | 30 |
Others |  |  | 323 |  |  |  | 411 |
Total |  |  | 5,676 |  |  |  | 5,923 |
Less non-current portion |  |  | (3,567 | ) |  |  | (3,800 | )
Current portion |  |  | 2,109 |  |  |  | 2,122 |
We receive government conditional advances and grants for advanced research programs we conduct alone or in connection with other unrelated entities (mainly HECAM project) which are provided for and managed by French state-owned entities, and specifically “Banque Publique d’Investissement” (“Bpifrance”). We, alone or with other unrelated entities, enter into multi-year contractual arrangements for the financing of specific research programs. These arrangements consist of both grants and conditional advances which are paid in fixed instalments at predetermined contractual dates, subject generally to milestones based on progress of the research and documentation. Grants received are non-refundable. Conditional advances received are subject to a fixed 1.44% interest rate. If and when the research program is considered a commercial success, contractual repayment is required. In addition, if we decide to stop the research program, the conditional advance may be repayable. Grants that relate to expenses we incur for this research program are recognized in the line item “Research and Development Expenses” in the period in which the expenses subject to the grants have been incurred (see Note 20 ). Conditional advances as of December 31, 2019 mature as follows, should the underlying Research Program advance as per contract:
2020 |  |  | - |
2021 |  |  | 6 |
2022 |  |  | 209 |
2023 |  |  | 209 |
2024 and thereafter |  |  | 646 |
Total |  |  | 1,071 |
Changes in the provision for warranty costs are as follows:
|  | December 31,
|  | 2019 |  | 2018
Beginning of year |  |  | 547 |  |  |  | 449 |
Amount used during the year |  |  | (308 | ) |  |  | (335 | )
New warranty expenses |  |  | 131 |  |  |  | 433 |
End of year |  |  | 370 |  |  |  | 547 |
Less current portion |  |  | (260 | ) |  |  | (356 | )
Long term portion |  |  | 110 |  |  |  | 191 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for other liabilities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20,24) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_OtherLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration